(16(17)-DiHDPA
(16(17)-DiHDPA Basic information
- Product Name:
- (16(17)-DiHDPA
- Synonyms:
-
- (16(17)-DiHDPA
- (±)16(17)-DiHDPA MaxSpec? Standard
- 16,17-dihydroxy-4(Z),7(Z),10(Z),13(Z),19(Z)-docosapentaenoic acid
- 4,7,10,13,19-Docosapentaenoic acid, 16,17-dihydroxy-, (4Z,7Z,10Z,13Z,19Z)-
- (±)16(17)-DiHDPA
- 16,17-Dihydroxy-4(Z),7(Z),10(Z),13(Z),19(Z)-DPA
- CAS:
- 1345275-27-5
- MF:
- C22H34O4
- MW:
- 362.5
- Mol File:
- 1345275-27-5.mol
More
Less
(16(17)-DiHDPA Chemical Properties
- Boiling point:
- 537.8±50.0 °C(Predicted)
- Density
- 1.035±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): 0.25 mg/ml
- pka
- 4.58±0.10(Predicted)
More
Less
(16(17)-DiHDPA Usage And Synthesis
Description
(±)16(17)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid (DHA; ). It has been shown to inhibit VEGF-induced angiogenesis and reduce cancer cell metastasis in mice.1
Uses
(±)16(17)-DiHDPA is a epoxygenase metabolite of docosahexaenoic acid (HY-B2167). (±)16(17)-DiHDPA inhibits platelet aggregation at concentrations below those affecting thromboxane synthesis[1][2].
Definition
ChEBI: 16,17-DiHDPE is a very long-chain fatty acid.
References
1. Zhang, G., Panigrahy, D., Mahakian, L.M., et al. Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis Proc. Natl. Acad. Sci. USA 110(16),6530-6535(2013).
(16(17)-DiHDPASupplier
Yichang Zhongyitai Trading Co., Ltd.
- Tel
- 0717-6449896 13886658719
- root@zhongyitai.com
Alfa Chemistry
- Tel
- 1-516-6625404
- support@alfa-chemistry.com
Shanghai Hongye Biotechnology Co. Ltd
- Tel
- 400-9205774
- sales@glpbio.cn
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
- Tel
- 18818260767
- sales@chemegen.com
Shanghai Yifei Biotechnology Co. , Ltd.
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com